摘要
Purpose Disulfiram (DSF) has been proven safe and shows the promising antitumor effect in preclinical studies. However, the precise mechanism of DSF on tumor is rarely reported. This study aims to fully understand the mechanism of action of DSF with a systems perspective in anticancer effects. Experimental Design SILAC-based quantitative proteomics strategy was used to systematically identify differential expression proteins (DEPs) after DSF treatment in HeLa cells. Bioinformatical analysis (PANTHER, DAVID, and STRING) were performed to characterize biological functions of DEPs. Functional studies were performed to explore underlying mechanisms of DSF in cancer cells. Results In total, 201 proteins were dysregulated significantly after DSF exposure. Functional studies of hexokinase 2 (HK2), which catalyzed the first irreversible enzymatic step in glucose metabolism, revealed that various phenotypic effects observed after DSF treatment in cancer cells, at least partly, through the regulation of HK2 expression. Conclusions and Clinical Relevance By correlating the proteomics data with these functional studies, the current results provided novel insights into the mechanism underlying DSF function in cancer cells. Meanwhile, these provided theoretical basis for the new use of old drugs in clinical therapy.
学科与关键词
- Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathwayZheng, Peng*; Wu, Yaoqin; Wang, Yuqiong; Hu, Fan*Cellular Signalling, 2023, 109: 110771.被引 1
- Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viabilityYang, Xiao-Mei; Wu, Zheng; Wang, Xiaoqi; Zhou, Yaoqi; Zhu, Lei; Li, Dongxue; Nie, Hui-Zhen; Wang, Ya-Hui; Li, Jun*; Ma, Xueyun*BMC Pharmacology & Toxicology, 2022, 23(1): 54.被引 1
- Disulfiram-copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cellsLei, Wei; Xu, Jingkui; Ya, Yiyao; Zhang, Jinxiang; Hou, Xiuying; Zhai, Qiliang; Zha, Zeyu; Zhuo, Yangjia; Zhou, You; Yuan, Hong; Liang, Yuxiang; Han, Zhaodong; Zhong, Weide; Zhu, Linyan*; Chen, Yehui*Asia-Pacific Journal of Clinical Oncology, 2022, 18(2): E46-E55.被引 2
